Karen Gelmon MDMedical Oncologist, Department of Medical Oncology, British Columbia Cancer Agency; Professor of Medicine, University of British Columbia, Vancouver, British Columbia
Dr. Karen Gelmon is a Professor of Medicine at the University of British Columbia and a Medical Oncologist at the British Columbia Cancer Agency (BCCA), combining clinical and translational research. She is Co-Chair of the Breast Site Committee for the NCIC Clinical Trials Group (CTG) and a member of the NCI Breast Steering Committee and of the BIG (Breast International Group) Advisory Group. She sits on the NCIC-CTG IND Executive Committee and is a past Chair of this committee. She is also a Komen Scholar and member of the Scientific Advisory Council for Komen. She is Co-Chair of the Scientific Advisory Council of the Ontario Institute of Cancer Research. She is Clinical Leader of the Advanced Therapeutics department at the BCCA.
Dr. Gelmon is an active teacher, interested in education of healthcare professionals and the public; she has published extensively. She sits on the International Advisory Board of The Lancet, The Oncologist, and Clinical Breast Cancer. She has been Chair for the Breast Cancer Track at ASCO and is currently on the Education Committee. She has been a member of the board of the British Columbia Cancer Foundation and the Medical Advisory Board of the British Columbia/Yukon Chapter of the Canadian Breast Cancer Foundation, and currently sits on the board of Rethink Breast Cancer.
In 2003, Dr. Gelmon was the recipient of a YWCA Woman of Distinction award. She is the mother of two daughters and is active on volunteer boards for the arts and community in Vancouver.